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Abstract 
Alzheimer’s disease (AD) degrades the brain’s ability to remember, think, and carry out tasks. The exact 
cause is not known, but several risk factors have been identified, including diabetes mellitus (DM). DM causes 
elevated blood sugar levels due to reduced insulin production in the pancreas. The linkage between elevated 
glucose levels and the behavioral impairments are not fully understood, which was the focus of this study. Rats 
were trained to alternate directions in a maze to receive a reward on consecutive trials. After training, five rats 
were injected with streptozotocin (STZ), which induces hyperglycemia by injuring pancreatic beta cells. Three 
control animals received benign vehicle injections. All eight rats then underwent implant surgery and received 
an implant with 128 recording probes attached to an electronic interface board. The recording electrodes 
targeted the hippocampus and the anterior cingulate cortex (ACC), which are both associated with learning and 
memory processes. We found that STZ rats had reduced accuracy after long delay periods compared to the 
control rats. During task performance, there was a decrease in the power of theta activity and an increase in 
delta activity moments before starting a new trial. This was the opposite of control animals, who before starting 
new trials had higher theta power and less delta power as they focused. These findings imply that the STZ rats 
were impaired on longer delay periods. These findings are like reports from animal models of AD and may help 
explain why DM is a risk factor for AD. 
 
Keywords: Alzheimer’s disease, diabetes mellitus, streptozotocin, learning, memory, working memory, 
anterior cingulate cortex, hippocampus 
 
Diabetes mellitus (DM) and Alzheimer’s 
disease (AD) are prevalent diseases within our 
population that affect millions of people worldwide 
and can serve to be quite deadly. In 2013, the sixth 
leading cause of death in the United States was AD 
(Alzheimer’s Association) and DM was the eighth 
leading cause of death (Tao et al., 2015). AD is a 
form of dementia that is most prevalent in elderly 
populations and is categorized by deficits in cortical 
function, specifically memory (Becker et. al, 1994). 
DM is categorized by elevated blood glucose levels, 
also known as hyperglycemia, and can occur due to 
dysfunction of insulin production or secretion 
(American Diabetes Association, 2014). Recently, it 
has been shown that DM is likely to be a risk factor 
for the development of Alzheimer’s disease (Li, 
Wang, & Xiao, 2016). This is problematic since AD 
does not present the full extent of its symptoms until 
much later into the disease, and by this stage of the 
disease there are very few effective treatments known 
today. Both diseases fall within the top ten leading 
causes of mortality and understanding comorbidity 
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interactions can uncover how memory, specifically 
working memory, is affected by hyperglycemic states. 
The focus of this study was placed on changes in 
working memory in hyperglycemic rodents. To 
investigate any changes in working memory, brain 
structures tasked with the consolidation and retrieval 
of memory were focused on.  
Two brain areas that have shown to be integral 
to understanding the underlying pathologies of 
memory from DM are the anterior cingulate cortex 
(ACC) and the hippocampus (HC). The ACC is active 
in relation to emotional behavior and decision-making 
regarding rewards (Rolls, 2019). The HC is also 
known to be involved in declarative, episodic, (Opitz, 
2014), and spatial memory (Schlesiger et. al, 2013). 
In rodents, ablation to the hippocampal area removes 
the ability to complete a delayed alternation task 
(Racine & Kimble, 1965). Also, previous studies have 
shown that treating hyperglycemia in humans can 
improve cognition and working memory test scores 
(Ryan et. al, 2006).  
In our model organisms, DM is induced with 
the neoplastic agent streptozotocin (STZ), and it is 
known to induce an elevated blood glucose or DM-
like state in rodents (Murtishaw et. al, 2018). 
Hyperglycemic states have been implicated in leading 
to cognitive decline in relation to memory function, 
even when the individual does not meet the threshold 
for a clinical diagnosis of type 2 diabetes (Marden et. 
al, 2017). Harvesting information from brain areas 
that are implicated in working memory and decision 
making when blood glucose levels are elevated will 
allow the advancement of future interventions that 
will hopefully treat and improve the status of DM.  
By understanding the effect on working 
memory by DM, a clearer picture of the cognitive 
implications of DM can be uncovered. Furthermore, 
measuring behavior modulations in hyperglycemic 
rodents can identify changes to the function of 
working memory. This distinction will help identify 
the relationship between the hallmark symptoms that 
define DM, which is hyperglycemia, and correlate any 
dementia-like symptoms with them.  
 
Methodology 
Eight Long-Evans rats were trained on a 
delayed alternation task in a custom-built T-maze. For 
the rats to have completed successful trials in 
succession, they would have had to travel left then 
right within the T-maze, and then repeat for their 
reward. The maze featured a sequester area where the 
rats would be forced to wait for a variable amount of 
time before proceeding onto the next trial. This 
required the animals to maintain the memory of the 
last trial over this delay period. When the rats were 
then released into the start area, they traveled some 
distance and encountered two separate pathways. At 
the end of one pathway, a reward was waiting for the 
rats while the other path contained no reward. This 
pattern alternated throughout consecutive trials. 
Five out of the eight rats received STZ 
injections, and three rats received a benign vehicle 
injections that contained a citrate buffer following 
training to ensure that the rodents could correctly 
complete the task. All injections were delivered 
intraperitoneally. The STZ animals exhibited average 
glucose levels of 358 ng/ml, with the threshold of 250 
ng/ml for a chronic state of hyperglycemia, 
commonly found in DM patients (Murtishaw et al., 
2018). Following surgery and adequate training in the 
T-maze, all of the rats underwent surgery for the 
implantation of a 128 channel hyperdrive recording 
probe. The implant surgery targeted the ACC as well 
as the HC, specifically the CA1 region. Wires were 
arranged in groups of four, which are known as 
tetrodes. The tetrodes were attached to an electronic 
interface board to properly record brain activity 
during the tasks. During surgery, the tetrodes were 
lowered into the HC and the ACC. All eight rats ran 
the task again while activity from both brain areas 
was recorded. Following recordings from the animal’s 
brain areas, the animals were sacrificed, and 
histological inspection confirmed that the electrodes 
were implanted in the target areas. 
Delta and theta waves are brain oscillations 
that are used to correlate brain activity with behavior. 
Theta waves are present during a task that involves 
active attention and focus (Buzsáki et. al, 1986), and 
are found between 7-12 Hz. Delta waves are 
correlated with resting states and are found between 
1-4 Hz (Fujisawa & Buzsáki, 2011). Figure 2 shows 
brackets denoting a period of delta (orange) and theta 
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Results 
Task Accuracy: The accuracy for STZ animals 
diminished after delay periods longer than 60 seconds 
and above compared to the control group (Figure 3). 
Within trials with delay periods of 60 seconds or less, 
both groups had similar accuracies of correct trials. 
This pattern persisted into the 60 second delay period 
with similar accuracies for STZ and control rats. 
Upon encountering a 90 second delay period, 
accuracy for STZ rats plummeted to 60% and 
plateaued at this accuracy level. The control group 
responded correctly to more than 10% of the trials 
compared to the STZ rats. In trials consisting of a 
delay period above 90 seconds, both groups 
responded with a similar accuracy. 
Differences in Delta and Theta Waves: Power 
differences in theta and delta waves within the HC 
were apparent between the two groups. Starting with 
the control group (left), the red band at ~7 Hz shows a 
constant theta power while the subjects waited for the 
trial start (Figure 4). Comparing these results to the 
STZ group, an increase in delta power (1 - 4 Hz) can 
be seen throughout the trial, which is not observed in 
the control group. Notice that there is a consistency of 
power throughout the time leading up to the trial start, 
denoted by the vertical dashed line, as well as a few 
seconds following in the control group. A slight 
fluttering of increased delta power can be seen leading 
up to the trial start in the STZ animals, which is 
absent within the control group. 
TD Ratio Shows Behavioral Difference: To parse out 
the amount of time that the animals spent in each type 
of behavioral condition, whether it was attentive or 
lethargic, a theta to delta (TD) ratio was calculated. 
The TD ratio will give an estimate of the animal’s 
behavior due to the correspondence between the 
specific waves and behavior. When comparing the TD 
ratio before the trial start within the control and 
experimental groups, the control groups persisted at a 
higher ratio (Figure 5). A higher TD ratio signifies 
that there was more theta activity than delta activity 
present while the animal was waiting the task to 
begin. The TD ratio of the experimental group was 
lower than the control group, which suggests that the 
STZ group was unable to focus and pursue the reward 
at the level that the control group was able to. Both 
groups showed an increase in TD ratio leading up to 
the trial start. 
Both groups received equal amounts of time 
for the trials in the experiment (Figure 6a). This was 
to ensure that every animal had equal opportunities to 
wait within the sequester area, as well as to keep the 
variable of delay time constant. The experimental and 
control groups remained at a constant weight for the 
first two weeks but differed in the amount of weight 
after 4 weeks of the vehicle injections, with the STZ 
group losing more weight compared to the control 
group (Figure 6b). 
 
Discussion 
These results show that elevated blood glucose 
levels have the capability to affect working memory 
during longer delay periods. Shorter delays were not 
as impaired in the hyperglycemic subjects, possibly 
implicating a disconnect between DM conditions and 
working memory. The memory deficits that preceded 
the hyperglycemic state mirror conditions seen in AD 
animal models and AD patients (Stopford et. al, 
2012). Even though the effects of hyperglycemia and 
working memory have been identified, much is still 
unknown about DM and AD. One connection 
between both diseases is the necessity of healthy 
blood glucose levels, as hypoglycemic states can also 
cause cognitive impairments (Sommerfield et. al, 
2003).  
Future studies that are looking to peer into 
hyperglycemia and its cognitive effects could also 
perform operations that investigate various pairwise 
combinations of other brain areas that are involved in 
learning and memory. These future areas should be 
highly integrated with either the hippocampus or 
ACC, like the orbitofrontal cortex (Rolls, 2019), 
which would require other mechanisms of 
investigation other than electrophysiology to parse out 
directly. One could also perturb one brain area and 
leave another intact, allowing for multiple pairwise 
combinations of impaired and non-impaired cortical 
regions. Aside from learning and memory 
impairments that are present with any patient with 
AD, other cognitive functions that are impaired could 
be investigated by examining other cortical areas that 
are associated with emotional arousal, like the 
amygdala. These findings also aid in furthering our 
focus on advanced glycosylation end products, which 
are known to affect cellular functions by and large, 
but the role of glycosylation in neural pathology is not 
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fully unraveled yet. By working from the molecular 
level up to the cognitive level, one could build upon 
how cellular processes involving glucose affect 
memory.   
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Note. Figure 1a: Custom built T-maze (left) shows the sequester area outlined in green, which was where the 
rodents waited for the trial to start. Both available pathways (purple and orange arrows) and reward areas are 
also shown. Figure 1b: Blood glucose levels were measured using a blood glucose index (BGI). Levels of BGI 
was measured and tracked through the time from the first injection of STZ to the time of the first recording 
session (right). All STZ animals were hyperglycemic at the time of the first recording session. 
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Appendix B: Figure 2. Delta and theta wave example 
 
 
Note. An example of electrical activity during a 6 second recording session through an EEG. The y-axis shows 
three separate EEG channels, and the x-axis denotes the time passed in milliseconds. The oscillating waves 
during the 1000-2000 ms period is an example of theta waves (purple), and delta waves are shown between the 
2500-3200 ms period (orange). 
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Appendix C: Figure 3. Task accuracy analysis 
 
 
Note. Differences in behavioral performance between groups is shown by comparing different delay periods 
with the percentage of correct trials completed. The accuracy of the correctly completed trials is on the y-axis 
and delay length in seconds is on the x-axis. Accuracy of the STZ group decreased after more than a 60 second 
delay period. 
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Appendix D: Figure 4. Power differences found within oscillations 
 
      
 
Note. Normalized power throughout the trial leading up to the trial start. Theta waves (~7-14 Hz) and delta 
waves (~1-4 Hz) are present in both graphs with different power. Frequency (Hz) is displayed on the y-axis, and 
time leading up to the trial start (TS) is on the x-axis. A dashed vertical line in each graph denotes the start of 
the trial. Normalized power (z) scale is shown in a blue to red gradient from -1 (low power) to 3 (high power). 
The STZ group showed a decrease in delta wave power compared to the control group leading up to the trial 
start, as well as a decrease in theta power. 
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Appendix E: Figure 5. TD ratio analysis 
 
 
Note. Normalized power throughout the trial leading up to the trial start. Theta waves (~7-14 Hz) and delta 
waves (~1-4 Hz) are present in both graphs with different power. Frequency (Hz) is displayed on the y-axis, and 
time leading up to the trial start (TS) is on the x-axis. A dashed vertical line in each graph denotes the start of 
the trial. Normalized power (z) scale is shown in a blue to red gradient from -1 (low power) to 3 (high power). 
The STZ group showed a decrease in delta wave power compared to the control group leading up to the trial 
start, as well as a decrease in theta power. 
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Note. Figure 6a: The percentage of change in body weight is shown throughout the weeks following the vehicle 
injections (STZ group) and citrate buffer (control group). Both groups increased in body weight throughout the 
first eight weeks (left). Figure 6b: All animals from both groups received the same amount of time within each 
delay period (right). 
 
